HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R A A Mathôt Selected Research

Drug Therapy (Chemotherapy)

11/2002Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R A A Mathôt Research Topics

Disease

6Hemorrhage
02/2022 - 03/2016
4Hemophilia B (Haemophilia B)
02/2022 - 01/2017
3Body Weight (Weight, Body)
11/2018 - 03/2016
3Hemophilia A (Haemophilia)
01/2018 - 03/2016
2Acute Kidney Injury (Acute Renal Failure)
10/2021 - 01/2018
2Neoplasms (Cancer)
06/2004 - 10/2002
1Cystic Fibrosis (Mucoviscidosis)
01/2022
1Critical Illness (Critically Ill)
10/2021
1Chronic Kidney Failure (Chronic Renal Failure)
10/2021
1Infections
11/2020
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2020
1von Willebrand Diseases (von Willebrand's Disease)
05/2018
1Wounds and Injuries (Trauma)
05/2018
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2018
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
04/2013
1Sarcoma (Soft Tissue Sarcoma)
08/2003
1Stomach Neoplasms (Stomach Cancer)
02/2003
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2002
1Alopecia (Baldness)
11/2002
1Xerostomia
07/2002
1HIV Infections (HIV Infection)
07/2002
1Oral Candidiasis (Thrush)
07/2002
1Candidiasis (Moniliasis)
07/2002

Drug/Important Bio-Agent (IBA)

4Factor IX (Coagulation Factor IX)FDA LinkGeneric
02/2022 - 01/2017
2Pharmaceutical PreparationsIBA
01/2022 - 11/2002
2Factor VIII (Coagulation Factor VIII)IBA
01/2018 - 03/2016
2Blood Coagulation Factors (Coagulation Factor)IBA
01/2018 - 01/2017
2Paclitaxel (Taxol)FDA LinkGeneric
02/2003 - 12/2002
1A-factor (Streptomyces)IBA
02/2022
1Clofazimine (Lamprene)FDA Link
01/2022
1Cytochrome P-450 CYP3AIBA
01/2022
1ivacaftor drug combination tezacaftorIBA
01/2022
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2022
1VancomycinFDA LinkGeneric
10/2021
1Ciprofloxacin (Cipro)FDA LinkGeneric
11/2020
1human F8 proteinFDA Link
01/2018
1Methotrexate (Mexate)FDA LinkGeneric
01/2018
1CreatinineIBA
01/2018
1Blood Group Antigens (Blood Groups)IBA
03/2016
1Methylphenidate (Ritalin)FDA LinkGeneric
04/2013
1phenethylamineIBA
04/2013
1TrabectedinIBA
08/2003
1Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2002
1Triethylenephosphoramide (TEPA)IBA
11/2002
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
11/2002
1Carboplatin (JM8)FDA LinkGeneric
11/2002
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2002
1SulfonamidesIBA
10/2002
1N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA
10/2002
1Antineoplastic Agents (Antineoplastics)IBA
10/2002
1Anti-Retroviral Agents (Antiretroviral Agents)IBA
07/2002
1Fluconazole (Zonal)FDA LinkGeneric
07/2002

Therapy/Procedure

5Therapeutics
07/2018 - 11/2002
4Operative Surgical Procedures
11/2018 - 03/2016
1Erythrocyte Transfusion
07/2018
1Drug Therapy (Chemotherapy)
11/2002
1CTCb regimen
11/2002
1Duration of Therapy
07/2002